By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: TriNetX LIVE Network Surpasses 300 Million Patients, Expanding Decision-Grade Evidence Across Global Healthcare
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > TriNetX LIVE Network Surpasses 300 Million Patients, Expanding Decision-Grade Evidence Across Global Healthcare
TriNetX LIVE Network Surpasses 300 Million Patients, Expanding Decision-Grade Evidence Across Global Healthcare
News

TriNetX LIVE Network Surpasses 300 Million Patients, Expanding Decision-Grade Evidence Across Global Healthcare

Last updated: 23/06/2026 11:39 PM
Published: 23/06/2026
Share
SHARE

The milestone reflects accelerating international growth and gives pharmaceutical companies, academic researchers, healthcare providers, and health-tech innovators access to trusted, current, clinically rich, and globally representative real-world data.

- Advertisement -

CAMBRIDGE, Mass., June 23, 2026 /PRNewswire/ — TriNetX, the world’s leading federated health data network, today announced that its TriNetX LIVE™ network has surpassed 300 million patients, a single, federated source of EHR-native real-world data spanning 240+ healthcare organizations and 13,000+ sites worldwide. The milestone expands the decision-grade evidence available to organizations working to improve patient care.

- Advertisement -

Real-world data have historically been fragmented. Discovery teams use one source, trial design teams another, and post-market safety another, with each handoff costing time and introducing inconsistency. A single, harmonized 300-million-patient network supports every stage, from hypothesis generation and target identification in early discovery to recruitment, comparative effectiveness, label expansion, and pharmacovigilance after launch.

- Advertisement -

“Three hundred million is a milestone, not a destination,” said Steve Lethbridge, Senior Vice President of Global Healthcare Partnerships at TriNetX. “What 300 million patients enables matters more than the number itself. Wherever in the healthcare ecosystem someone is making decisions that affect patient outcomes, the difference between a defensible decision and a guess comes down to whether the data are trusted, current, clinically rich, and global. That is what this network delivers.”

- Advertisement -

The network’s fastest growth is happening outside the U.S. Of the roughly 52 million patients added April 2025–April 2026, the majority came from international markets. The network now spans 186 million patients in the U.S., 72 million across EMEA, 23 million in Latin America, and 21 million in APAC.

- Advertisement -

That international breadth is not incidental. It is built into how the network operates. Rather than aggregated extracts repackaged by an intermediary, the TriNetX LIVE™ network is live and bi-directional: data flow continuously from EHR systems at participating healthcare organizations, refreshed in near real time and with full clinical context intact.

- Advertisement -

Request a demo to see how the TriNetX LIVE™ network can help your organization turn real-world data into decision-grade evidence.

- Advertisement -

About TriNetX, LLC

- Advertisement -

TriNetX is The Global Truth Engine for Better Human Health™, helping organizations understand what’s really happening in patient care. We connect health systems, researchers, and companies around the globe to real world patient data so they can make better informed decisions — based on reality, not assumptions.

- Advertisement -

Data are sourced directly from 13,000+ healthcare provider sites across more than 20 countries and kept within those institutions to protect accuracy, privacy, and trust. TriNetX combines this data with scientific expertise and technology to help customers ask better questions, interpret results, and move forward with confidence.

- Advertisement -

Learn more at www.trinetx.com or follow TriNetX on LinkedIn.

- Advertisement -

Media Contact
TriNetX
Karen Tunks
Email: Karen.Tunks@TriNetX.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/542641/TriNetX_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/trinetx-live-network-surpasses-300-million-patients-expanding-decision-grade-evidence-across-global-healthcare-302806670.html

- Advertisement -
NYSE Content Update: Business Leaders Come Together for No Kid Hungry Campaign
Bybit Powers up Black Friday with Extra Rewards Throughout November
India’s ESG Champions Awarded at Dun & Bradstreet’s ESG Leadership Summit 2025
Vieworks Completes Major Expansion of Hwaseong Manufacturing Site, Doubling Production Capacity
Every Step Counts: Manipal Hospital Millers Road Hosts Walkathon to Promote Active Living
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Ministry of Education of Jordan begins transformative national literacy initiative using Amira Learning
News

Ministry of Education of Jordan begins transformative national literacy initiative using Amira Learning

30/01/2026
PHANTASTICUS PICTURES ANNOUNCES THE INTERNATIONAL RELEASE OF VANTARA: SANCTUARY STORIES, PREMIERING ON DISCOVERY INTERNATIONAL PLATFORMS THIS SPRING
FioBit: Smart Passive Income Investments for 2025 Earn Free Cryptocurrency with Trusted US Cloud Mining Apps
The Volpi Rosse Menarini: The ‘Fantastic Ten’ are ready for the 2025 – 2026 Season
ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?